The University of Southampton
University of Southampton Institutional Repository

The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders

The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders
The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders
chronic myelomonocytic leukaemia, eosinophilia, mastocytosis, myelodysplastic/myeloproliferative neoplasms, myeloproliferative neoplasms
0007-1048
338-351
Cross, Nicholas
f87650da-b908-4a34-b31b-d62c5f186fe4
Godfrey, Anna L.
d0477b25-bba7-4c1e-8d2e-6937a2e69c24
Cargo, Catherine
cbefd897-63d6-4f2c-9bcc-67f1146dc3d7
Garg, Mamta
2d17d199-6ea1-4864-9838-a2376690d0ef
Mead, Adam J.
5b041fae-0381-4ac5-a112-6d11550f112d
Cross, Nicholas
f87650da-b908-4a34-b31b-d62c5f186fe4
Godfrey, Anna L.
d0477b25-bba7-4c1e-8d2e-6937a2e69c24
Cargo, Catherine
cbefd897-63d6-4f2c-9bcc-67f1146dc3d7
Garg, Mamta
2d17d199-6ea1-4864-9838-a2376690d0ef
Mead, Adam J.
5b041fae-0381-4ac5-a112-6d11550f112d

Cross, Nicholas, Godfrey, Anna L., Cargo, Catherine, Garg, Mamta and Mead, Adam J. (2021) The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders. British Journal of Haematology, 195 (3), 338-351. (doi:10.1111/bjh.17766).

Record type: Article
Text
Cross BJH 2021 for PURE - Accepted Manuscript
Download (387kB)

More information

Accepted/In Press date: 28 July 2021
e-pub ahead of print date: 18 August 2021
Published date: November 2021
Additional Information: Funding Information: All authors have made a declaration of interests to the BSH and Task Force Chairs which may be viewed on request. NCPC has received honoraria for advisory boards and research support from Novartis and advisory boards from Incyte; ALG and CC have received honoraria as speakers for Novartis and advisory boards for AOP Orphan Pharmaceuticals; AJM has received honoraria from Novartis, Bristol Myers Squibb/Celgene, CTI BioPharma and AbbVie and has received research funding from Novartis, Bristol Myers Squibb/Celgene, and CTI BioPharma. MG has no conflicts of interest to declare. © 2021 British Society for Haematology and John Wiley & Sons Ltd
Keywords: chronic myelomonocytic leukaemia, eosinophilia, mastocytosis, myelodysplastic/myeloproliferative neoplasms, myeloproliferative neoplasms

Identifiers

Local EPrints ID: 450704
URI: http://eprints.soton.ac.uk/id/eprint/450704
ISSN: 0007-1048
PURE UUID: 7fc196a3-c1c5-4478-8ac6-cee8bd61f326
ORCID for Nicholas Cross: ORCID iD orcid.org/0000-0001-5481-2555

Catalogue record

Date deposited: 06 Aug 2021 16:32
Last modified: 17 Mar 2024 06:45

Export record

Altmetrics

Contributors

Author: Nicholas Cross ORCID iD
Author: Anna L. Godfrey
Author: Catherine Cargo
Author: Mamta Garg
Author: Adam J. Mead

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×